Patents by Inventor Christine Moore

Christine Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mobile device with predictive routing engine
    Patent number: 11934961
    Abstract: A mobile device with a route prediction engine is provided that can predict current/future destinations or routes to destinations for the user, and can relay prediction information to the user. The engine includes a machine-learning engine that facilitates the formulation of predicted future destinations and/or future routes to destinations based on user-specific data. The user-specific data includes data about (1) previous destinations traveled, (2) previous routes taken, (3) locations of calendared events, (4) locations of events for which the user has electronic tickets, and/or (5) addresses parsed from e-mails and/or messages. The prediction engine relies on one or more of user-specific data stored on the device and data stored outside of the device by external devices/servers.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: March 19, 2024
    Assignee: Apple Inc.
    Inventors: Christine B. McGavran, Bradford A. Moore, Gregory D. Bolsinga, Michael P. Dal Santo, Lukas Marti, Seejo K. Pylappan, Marcel van Os
  • Genes and proteins, and their use
    Publication number: 20090274717
    Abstract: According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines to immunize a patient against microbial infection.
    Type: Application
    Filed: August 17, 2007
    Publication date: November 5, 2009
    Applicant: Emergent Product Development UK Limited
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Gordon Dougan, Rebecca Kerry Wilson
  • Genes and proteins, and their use
    Patent number: 7592011
    Abstract: A protein from Group B Streptococcus is shown to be an outer surface protein and is a useful target for antimicrobial therapy.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: September 22, 2009
    Assignee: Emergent Product Development UK Limited
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Gordon Dougan, Rebecca Kerry Wilson
  • Outer surface proteins, their genes, and their use
    Publication number: 20080226641
    Abstract: According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be located on the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines for the immunization of a patient against microbial infection.
    Type: Application
    Filed: August 17, 2007
    Publication date: September 18, 2008
    Applicant: Emergent Product Development UK Limited
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Caroline Joanne Henwood, Gordon Dougan, Rebecca Kerry Wilson
  • Genes and proteins, and their use
    Patent number: 7419672
    Abstract: According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines to immunize a patient against microbial infection.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: September 2, 2008
    Assignee: Emergent Product Development UK Limited
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Gordon Dougan, Rebecca Kerry Wilson
  • GENES AND PROTEINS, AND THEIR USE
    Publication number: 20080181908
    Abstract: According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines to immunize a patient against microbial infection.
    Type: Application
    Filed: March 12, 2004
    Publication date: July 31, 2008
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Gordon Dougan, Rebecca Kerry Wilson
  • Microfluidic Biofuel Cell
    Publication number: 20070287034
    Abstract: Microfluidic biofuel cells comprising a bioanode and/or a biocathode are formed using microfluidic principles and soft lithography. The enzymes utilized in the redox reactions at the bioanode and/or the biocathode are stabilized in a micellar or inverted micellar structure. The biofuel cell is used to produce high power densities.
    Type: Application
    Filed: January 19, 2005
    Publication date: December 13, 2007
    Applicant: SAINT LOUIS UNIVERSITY
    Inventors: Shelley Minteer, Robert Martin, Christine Moore
  • NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use
    Patent number: 7217415
    Abstract: According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be located on the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines for the immunization of a patient against microbial infection.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: May 15, 2007
    Assignee: Emergent Product Development UK Limited
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Caroline Joanne Henwood, Gordon Dougan, Rebecca Kerry Wilson
  • Methods for selectively removing counterions from compounds and compounds derived from such methods
    Patent number: 6995281
    Abstract: Methods of selectively removing counterions from compounds are disclosed. Compounds derived from the methods, such as the compound S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine zwitterion with between zero and up to 2 molar equivalents of hydrochloride are also disclosed.
    Type: Grant
    Filed: March 10, 2004
    Date of Patent: February 7, 2006
    Assignee: Pfizer, Inc.
    Inventor: Christine Moore
  • Genes and proteins, and their use
    Patent number: 6890539
    Abstract: A protein from Group B Streptococcus is shown to be an outer surface protein and is a useful target for antimicrobial therapy.
    Type: Grant
    Filed: March 11, 2002
    Date of Patent: May 10, 2005
    Assignee: Microscience, Ltd.
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Gordon Dougan, Rebecca Kerry Wilson
  • Methods for selectively removing counterions from compounds and compounds derived from such methods
    Publication number: 20040225150
    Abstract: Methods of selectively removing counterions from compounds are disclosed. Compounds derived from the methods, such as the compound S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine zwitterion with between zero and up to 2 molar equivalents of hydrochloride are also disclosed.
    Type: Application
    Filed: March 10, 2004
    Publication date: November 11, 2004
    Inventor: Christine Moore
  • Genes and proteins and their use
    Patent number: 6812021
    Abstract: According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vacaccines to immunize a patient against microbial infection.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: November 2, 2004
    Assignee: Microscience Limited
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Gordon Dougan, Rebecca Kerry Wilson
  • Genes and proteins, and their use
    Publication number: 20030104000
    Abstract: A protein from Group B Streptococcus is shown to be an outer surface protein and is a useful target for antimicrobial therapy.
    Type: Application
    Filed: March 11, 2002
    Publication date: June 5, 2003
    Inventors: Martin John Glenton Hughes, Joseph David Santangelo, Jonathan Douglas Lane, Robert Feldman, Joanne Christine Moore, Richard James Dobson, Paul Everest, Gordon Dougan, Rebecca Kerry Wilson